Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Evolution of the CNS myelin gene regulatory program.
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible?
Restless legs syndrome in multiple sclerosis.
Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
[Differntial diagnosis of neuromyelitis optica].
A proposed roadmap for inpatient neurology quality indicators.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR-CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.
[Thoughts on hot issues of neuromyelitis optica].
Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.
Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.

Pages